New weapon against tough cancers: experimental drug enters human testing
Disease control
Recruiting now
This early-stage trial is testing a new drug called TTX-080, both alone and combined with other cancer therapies, for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and see if the drug shows any signs o…
Phase: PHASE1 • Sponsor: Tizona Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC